Ph.D. Jonas BERGH Professor, Department of Oncology-Pathology, Karolinska Institutet, Stockholm
CV
1973-1979 | Medical School, Umeå and Uppsala University, Sweden (MD) |
1980-1982 | Internship (Internal Medicine, Anaesthesiology, Surgery, Psychiatry, GP) Uppsala University Hospital, license to practice medicine in Sweden |
1982 | PhD in Pathology/Tumour biology, University of Uppsala |
1979-1980 | and 1982-1988 Clinical training and Education in Pathology and Oncology |
1986 | Board certified in Pathology in Sweden; Board certified in Oncology, includes Medical Oncology and Radiotherapy |
1986-1998 | Associate Professor in Experimental Oncology, Uppsala University |
1988 | Licence to practice medicine, specialist in Clinical Oncology UK 2/9, 2009 |
1988-1998 | Senior registrar, assistant consultant and consultant, Dept of Oncology, University Hospital, Uppsala, Sweden |
since 1999 | Consultant, Karolinska University Hospital, Radiumhemmet (20% from October 2009) |
2000-2008 | Professor of clinical and molecular oncology, Karolinska Institutet |
since 2008 | Professor of Oncology (Mimi Althainz´ donation, the first chair in radiotherapy, later transferred to oncology in Sweden), Karolinska Institutet |
2007-2009 | Scientific Director Karolinska Oncology and Medical Director for the Clinical Trial Unit |
since 2009 | Chairman for the Oncology-Haematology expert group (LÄKSAK), Stockholm County Council |
Professor of Breast Oncology, Paterson Institute/Manchester University | |
Honorary consultant at the Breast Unit, Medical Oncology Unit, Christie Hospital and Director Manchester Breast Centre |
Mitgliedschaften
Chairman, Swedish Breast Cancer Group | |
Appointed Member, Ethical Committee, Karolinska Institutet | |
External Expert, Medical Products Agency and EMEA, London | |
Member, Oncology Scientific Advisory Group of the EMEA, London | |
Elevator, European Union Commission for the BIOMED 6th Framework Programmes, 1995, 1997, 2003 | |
Member, Priority Committee, 1999-2007 | |
Research Board, Swedish Cancer Society, 2002-2008 | |
External expert, Swedish Board for Health and Welfare, 2002-2007 | |
Member, St. Gallen Consensus Panel, 2003, 2005, 2007, 2009 | |
Member, EBCTCG Steering Committee, since 2005 | |
Member, American Society for Clinical Oncology, American Association for Cancer Research | |
Member, Swedish Society for Oncology, The Swedish Medical Society |
Publikationen
He is author/co-author of some 300 articles, manuscripts and reviews, and is a member of the Editorial Boards of Acta Oncologica, Breast Cancer Online, Anticancer Research and Current Cancer Therapy Reviews. More than 11.000 citations, h-index of 49. |